Zachary Greenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zachary Greenberg has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Mei He
Department of Pharmaceutics, College of Pharmacy University of Florida Gainesville Florida USA
35 shared publications - Kiley Graim
Department of Computer & Information Science & Engineering, University of Florida, Gainesville, USA
27 shared publications - Thomas D. Schmittgen
Department of Pharmaceutics, College of Pharmacy, University of Florida
27 shared publications - Abu Talha Siddique
Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida
26 shared publications - Alexander Krasnitz
Cold Spring Harbor Laboratory
26 shared publications - Astrid Deschênes
Cancer Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
26 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 15 (11)
Extracellular Vesicles for Space Biomedical Research
Extracellular vesicles (EVs) are regulated, information‐rich nanovesicles that reflect aspects of parent‐cell state, making them promising readouts on biological adaptation. Microgravity perturbs mechanotransduction, mitochondrial stress and quality control, and autophagy‐endolysosomal trafficking, processes that can reshape EV biogenesis and cargo selection. However, spaceflight EV studies remain sparse and methodologically inconsistent, complicating mechanistic interpretation and cross‐mission comparison. In this review, we define an EV‐centred framework that links microgravity‐sensitive changes in cytoskeletal tension, membrane trafficking, mitochondrial quality control, and autophagy‐endolysosomal routing to four measurable EV outputs: concentration, subtype balance, surface phenotype, and molecular cargo. We use this framework to organize current evidence from spaceflight and simulated microgravity studies, while considering the limitations introduced by heterogeneous isolation and characterization methods. We then examine microgravity‐relevant EV culture systems, including high‐density three‐dimensional tissues, organoids, spheroids, and perfused tissue chips that support serial collection of conditioned media or effluent, together with compact capture and concentration approaches and core characterization strategies. Finally, we discuss the potential use of EVs as longitudinal liquid‐biopsy readouts of stress and aging‐like trajectories, as regenerative products relevant to musculoskeletal, vascular, and immune risks, and as engineered delivery vehicles. We identify EV uptake and biodistribution under altered gravity as a major translational gap and emphasize the need for standardized workflows that improve experimental rigor and biological interpretation in spaceflight research.
- 5 November 2026
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 15 (11)
Open AccessExtracellular Vesicles for Space Biomedical Research
Extracellular vesicles (EVs) are regulated, information‐rich nanovesicles that reflect aspects of parent‐cell state, making them promising readouts on biological adaptation. Microgravity perturbs mechanotransduction, mitochondrial stress and quality control, and autophagy‐endolysosomal trafficking, processes that can reshape EV biogenesis and cargo selection. However, spaceflight EV studies remain sparse and methodologically inconsistent, complicating mechanistic interpretation and cross‐mission comparison. In this review, we define an EV‐centred framework that links microgravity‐sensitive changes in cytoskeletal tension, membrane trafficking, mitochondrial quality control, and autophagy‐endolysosomal routing to four measurable EV outputs: concentration, subtype balance, surface phenotype, and molecular cargo. We use this framework to organize current evidence from spaceflight and simulated microgravity studies, while considering the limitations introduced by heterogeneous isolation and characterization methods. We then examine microgravity‐relevant EV culture systems, including high‐density three‐dimensional tissues, organoids, spheroids, and perfused tissue chips that support serial collection of conditioned media or effluent, together with compact capture and concentration approaches and core characterization strategies. Finally, we discuss the potential use of EVs as longitudinal liquid‐biopsy readouts of stress and aging‐like trajectories, as regenerative products relevant to musculoskeletal, vascular, and immune risks, and as engineered delivery vehicles. We identify EV uptake and biodistribution under altered gravity as a major translational gap and emphasize the need for standardized workflows that improve experimental rigor and biological interpretation in spaceflight research.
- Open Access
- 30 April 2026
- Published by Wiley in Journal of Extracellular Biology
- Vol. 5 (5) , e70141
Urinary Extracellular Vesicles for High‐Precision Bladder Cancer Subtyping and Prognosis
Bladder cancer (BCa) exhibits molecular heterogeneity that complicates early diagnosis and prognosis, and drives confounding clinical outcomes. Non‐muscle invasive and muscle‐invasive subtypes, especially for intermediate to high grade, carry a 25%–50% progression‐free survival rate, underscoring the need for high‐precision prognostic strategy. Urinary extracellular vesicles (uEVs) are promising carriers of tumour‐derived RNAs and proteins. However, significant challenges in studying uEVs arise from the diverse cellular origin of uEVs associated with the dynamic composition of urine, which presents roadblocks for developing the clinical utility of uEVs. We developed an AI‐driven EV liquid biopsy pipeline that integrates (1) standardised EV isolation via NanoPom magnetic beads, (2) transcriptomic profiling for molecular subtyping and (3) prognostic scoring algorithm. In a discovery cohort of 16 BCa patients including both muscle‐invasive bladder cancer (MIBC) and non‐muscle‐invasive bladder cancer (NMIBC), we compared NanoPom isolated uEVs with ExoEasy and Fujifilm MagCapture isolated uEVs, for identifying BCa subtype‐specific gene signatures, and externally validated them using UCSC Xena. The result outperformed currently reported BCa diagnostic biomarkers from assays including Galeas, CxBladder and Xpert. In a validation cohort composed of seven individuals with MIBC, NMIBC and healthy individuals, we confirmed with plasma‐derived EVs for correlating with uEV biomarkers from NGS sequencing. The prognostic score stratified patients into low‐, intermediate‐ and high‐grade risk groups based on Xena's BCa survival outcomes. Our AI‐driven uEV liquid biopsy pipeline proves the concept for high precision BCa subtyping and prognosis, which could potentially facilitate treatment decision and lead to advanced profiling of bladder tumour biology using uEV liquid biopsy.
- 30 April 2026
- Published by Wiley in Journal of Extracellular Biology
- Vol. 5 (5) , e70141
Open AccessUrinary Extracellular Vesicles for High‐Precision Bladder Cancer Subtyping and Prognosis
Bladder cancer (BCa) exhibits molecular heterogeneity that complicates early diagnosis and prognosis, and drives confounding clinical outcomes. Non‐muscle invasive and muscle‐invasive subtypes, especially for intermediate to high grade, carry a 25%–50% progression‐free survival rate, underscoring the need for high‐precision prognostic strategy. Urinary extracellular vesicles (uEVs) are promising carriers of tumour‐derived RNAs and proteins. However, significant challenges in studying uEVs arise from the diverse cellular origin of uEVs associated with the dynamic composition of urine, which presents roadblocks for developing the clinical utility of uEVs. We developed an AI‐driven EV liquid biopsy pipeline that integrates (1) standardised EV isolation via NanoPom magnetic beads, (2) transcriptomic profiling for molecular subtyping and (3) prognostic scoring algorithm. In a discovery cohort of 16 BCa patients including both muscle‐invasive bladder cancer (MIBC) and non‐muscle‐invasive bladder cancer (NMIBC), we compared NanoPom isolated uEVs with ExoEasy and Fujifilm MagCapture isolated uEVs, for identifying BCa subtype‐specific gene signatures, and externally validated them using UCSC Xena. The result outperformed currently reported BCa diagnostic biomarkers from assays including Galeas, CxBladder and Xpert. In a validation cohort composed of seven individuals with MIBC, NMIBC and healthy individuals, we confirmed with plasma‐derived EVs for correlating with uEV biomarkers from NGS sequencing. The prognostic score stratified patients into low‐, intermediate‐ and high‐grade risk groups based on Xena's BCa survival outcomes. Our AI‐driven uEV liquid biopsy pipeline proves the concept for high precision BCa subtyping and prognosis, which could potentially facilitate treatment decision and lead to advanced profiling of bladder tumour biology using uEV liquid biopsy.
- Open Access
- 24 April 2026
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 11 (3) , e70134
Extracellular matrix microarchitecture modulates cellular behavior and extracellular vesicle phenotypes in biomimetic tendon models
Tendon disease is a highly prevalent musculoskeletal disorder characterized by extracellular matrix (ECM) disorganization and fibroblast activation, contributing to fibrotic tissue healing and impaired function. While extracellular vesicles (EVs) have emerged as key mediators of intercellular communication and drivers of fibrosis in various tissues, their role in tendon pathology remains poorly understood. In this study, we developed a physiologically relevant 3D in vitro model that recapitulates biophysical features of healthy and fibrotic tendon microenvironments to investigate EV‐mediated contributions to tendon remodeling. Primary tendon‐derived cells on diseased scaffolds had increased proliferation, higher collagen III and fibronectin protein expression, and inferior cellular alignment. Proteomic profiling of EVs revealed temporally regulated, microenvironment‐dependent cargo reflective of disease progression in vitro. Diseased EVs were enriched in cytoskeletal, ECM‐remodeling, and inflammatory proteins, including vimentin (VIM), Annexin A2 (ANXA2), MMP2, and INHBA, suggesting an EV‐mediated role in promoting matrix remodeling, fibroblast activation, and chronic inflammation. Notably, the temporal analysis demonstrated the late‐stage emergence of stress‐responsive and myofibroblast‐associated proteins such as ENO1 and DES, underscoring the model's ability to capture the progressive nature of tendon pathology. In contrast, EVs from the healthy mimetic model demonstrated cargo associated with metabolic homeostasis and lipid transport, including APOA2 and CKM. Collectively, these findings highlight the utility of our tendon model as a dynamic platform for studying tendon pathology and establishing EVs as both sensitive indicators of microenvironmental state and potential mediators of fibrotic progression. This work provides a foundation for future studies exploring the diagnostic and therapeutic potential of EVs in tendinopathy.
- 24 April 2026
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 11 (3) , e70134
Open AccessExtracellular matrix microarchitecture modulates cellular behavior and extracellular vesicle phenotypes in biomimetic tendon models
Tendon disease is a highly prevalent musculoskeletal disorder characterized by extracellular matrix (ECM) disorganization and fibroblast activation, contributing to fibrotic tissue healing and impaired function. While extracellular vesicles (EVs) have emerged as key mediators of intercellular communication and drivers of fibrosis in various tissues, their role in tendon pathology remains poorly understood. In this study, we developed a physiologically relevant 3D in vitro model that recapitulates biophysical features of healthy and fibrotic tendon microenvironments to investigate EV‐mediated contributions to tendon remodeling. Primary tendon‐derived cells on diseased scaffolds had increased proliferation, higher collagen III and fibronectin protein expression, and inferior cellular alignment. Proteomic profiling of EVs revealed temporally regulated, microenvironment‐dependent cargo reflective of disease progression in vitro. Diseased EVs were enriched in cytoskeletal, ECM‐remodeling, and inflammatory proteins, including vimentin (VIM), Annexin A2 (ANXA2), MMP2, and INHBA, suggesting an EV‐mediated role in promoting matrix remodeling, fibroblast activation, and chronic inflammation. Notably, the temporal analysis demonstrated the late‐stage emergence of stress‐responsive and myofibroblast‐associated proteins such as ENO1 and DES, underscoring the model's ability to capture the progressive nature of tendon pathology. In contrast, EVs from the healthy mimetic model demonstrated cargo associated with metabolic homeostasis and lipid transport, including APOA2 and CKM. Collectively, these findings highlight the utility of our tendon model as a dynamic platform for studying tendon pathology and establishing EVs as both sensitive indicators of microenvironmental state and potential mediators of fibrotic progression. This work provides a foundation for future studies exploring the diagnostic and therapeutic potential of EVs in tendinopathy.
- Open Access
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Figure S10. Increased expression of acinar transcription factors in Group 1 of NAT from independent cohort.
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Figure S10. Increased expression of acinar transcription factors in Group 1 of NAT from independent cohort.
- Open Access
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Figure S4. PCA based continental-level ancestry inference done with RAIDS software.
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Figure S4. PCA based continental-level ancestry inference done with RAIDS software.
- Open Access
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Supplemental Table 6. PI3K-AKT and Rho GTPase gene set used in Figure 5
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Supplemental Table 6. PI3K-AKT and Rho GTPase gene set used in Figure 5
- Open Access
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Figure 7 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Immune signaling is activated in the C/B subtype of normal pancreas and further enhanced in Black donors. The mean expression of (A) cytokines, (B), chemokines, and (C) cytokine receptors in normal pancreas tissue from the GTEx cohort. Mean expression values for the (D) cytokines, (E) chemokines, and (F) cytokine receptors stratified by subtype and self-identified race. Mean ± SD. Two-tailed Mann–Whitney U test. CPM, counts per million.
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 7 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Immune signaling is activated in the C/B subtype of normal pancreas and further enhanced in Black donors. The mean expression of (A) cytokines, (B), chemokines, and (C) cytokine receptors in normal pancreas tissue from the GTEx cohort. Mean expression values for the (D) cytokines, (E) chemokines, and (F) cytokine receptors stratified by subtype and self-identified race. Mean ± SD. Two-tailed Mann–Whitney U test. CPM, counts per million.
- Open Access
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Figure S8. Activation of PI3K-AKT and Rho GTPase pathways in Group 2 normal pancreas.
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Figure S8. Activation of PI3K-AKT and Rho GTPase pathways in Group 2 normal pancreas.
- Open Access
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Figure S2. GSEA of Group 1 and Group 2 data for 69 normal acinar specimens.
- 21 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
Figure S2. GSEA of Group 1 and Group 2 data for 69 normal acinar specimens.